+ All Categories
Home > Documents > 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and...

071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and...

Date post: 27-Apr-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
9
9/1/2017 1 Advancing Innovation in Pharmacy Practice: Working at the Top of Our Licenses Michael A. Moné, BSPharm, JD, FAPhA Alex Adams, Pharm.D., MPH Desi Kotis, Pharm.D., FASHP Michael Moné discloses that he is on the Board of ACPE All conflicts resolved through peer review Michael A. Moné, BSPharm, JD, FAPhA Objectives: Pharmacist Participants Explain the value that pharmacists and pharmacy technicians bring to both the profession and the public when they work at the top of their licenses. Describe recent innovations in pharmacist care List current barriers in state pharmacy practice acts that prevent expanded pharmacist care Discuss the expanded use of pharmacy technicians in hospitals and health‐systems Identify opportunities to expand pharmacist care Objectives: Technician Participants Explain the value that pharmacists and pharmacy technicians bring to both the profession and the public when they work at the top of their licenses. Describe recent innovations in pharmacist care List current barriers in state pharmacy practice acts that prevent expanded pharmacist care Discuss the expanded use of pharmacy technicians in hospitals and health‐systems Identify opportunities to expand pharmacist care Expectation Section 465.002, Florida Statutes: Legislative findings; intent.—The Legislature finds that the practice of pharmacy is a learned profession. 225 ILCS 85/1: The Practice of the Profession of Pharmacy in the State of Illinois is declared a professional practice affecting the public health, safety and welfare….practice of pharmacy, merit and receive the confidence of the public…. Learned Profession: three historical professions… law, theology, medicine Value Proposition Why do we have pharmacists?
Transcript
Page 1: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

1

Advancing Innovation in Pharmacy Practice:

Working at the Top of Our Licenses

Michael A. Moné, BSPharm, JD, FAPhA

Alex Adams, Pharm.D., MPH

Desi Kotis, Pharm.D., FASHP

Michael Moné discloses that he is on the Board of ACPE

All conflicts resolved through peer review

Michael A. Moné, BSPharm, JD, FAPhA

Objectives: Pharmacist Participants

• Explain the value that pharmacists and pharmacy technicians bring to both the profession and the public when they work at the top of their licenses.

• Describe recent innovations in pharmacist care

• List current barriers in state pharmacy practice acts that prevent expanded pharmacist care

• Discuss the expanded use of pharmacy technicians in hospitals and health‐systems

• Identify opportunities to expand pharmacist care

Objectives: Technician Participants

• Explain the value that pharmacists and pharmacy technicians bring to both the profession and the public when they work at the top of their licenses.

• Describe recent innovations in pharmacist care

• List current barriers in state pharmacy practice acts that prevent expanded pharmacist care

• Discuss the expanded use of pharmacy technicians in hospitals and health‐systems

• Identify opportunities to expand pharmacist care

Expectation

• Section 465.002, Florida Statutes: Legislative findings; intent.—The Legislature finds that the practice of pharmacy is a learned profession.

• 225 ILCS 85/1:  The Practice of the Profession of Pharmacy in the State of Illinois is declared a professional practice affecting the public health, safety and welfare….practice of pharmacy, merit and receive the confidence of the public….

• Learned Profession: three historical professions… law, theology, medicine

Value PropositionWhy do we have pharmacists?

Page 2: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

2

Statutory Responsibilities

• Distill down the MUST obligations:• Accurate dispensing

• What are the elements that are MUST obligations• Product accuracy?

• Patient counseling• What are the elements that are MUST obligations

• Offer state?

• The ultimate question:  Is the practice of the pharmacy a profession?• What professional standard is applied to pharmacist practice?

Statutory/Regulatory Obligations

• How to practice at the top of the license?• Reduce the statutory and regulatory obligations that are not “value add” to the public

• Reduce the misperception within the profession of what is essential to meet the statutory/regulatory obligations to the public

• Empower pharmacy technicians who have demonstrated knowledge, experience and competence with tasks that do not involve clinical decision‐making, i.e. execution

• Shift obligations to the permit that are not clinical, i.e. remove the statutory/regulatory obligations from the PIC/PDM

Achievement of Value Proposition

• New Statutory/Regulatory Paradigm• For Pharmacists – the Negligence Standard

• What would a reasonably prudent pharmacist do under similar conditions and circumstances?  Prevailing community standard analysis

• Has the pharmacist kept up with the changes in pharmacy practice and are they competent as evidenced by circumstantial markers….CE, peer‐review, etc

• For Technicians – the Performance Standard

• Shifting task based activities to technicians the assessment becomes• Done or not done

• How is it done: correctly or not

How do Technicians Facilitate the Practice

• Knowledge• General or Core

• System Specific

• Experience

• Licensure• Accountability

• This will require a fundamental shift in how we regulate and how pharmacies manage the workplace

Examples of the change in concept

• Go West – The Village People• (Go west) Life is peaceful there.(Go west) Lots of open air.(Go west) To begin life new.(Go west) This is what we'll do.

• Oregon• During the 2015 Legislative Session, House Bill (HB) 2879 passed into law and was signed by Oregon Governor Kate Brown on July 6, 2015. The law is intended to develop standard procedures for the prescribing of hormonal contraceptive patches and oral contraceptives by an Oregon licensed pharmacist, providing timely access to care.

California

• As of August 10, 2016, pharmacists in California may now seek certification as an Advanced Practice Pharmacist (APP). 

• The 2013 bill created the APP designation which is required for community pharmacists to obtain in order to qualify to participate in collaborative practice agreements. The 2013 bill also expanded all pharmacists’ scope of practice by creating statewide protocols under which pharmacists can “furnish” (a.k.a. prescribe) certain products including self administered contraceptives, immunizations, travel medications, smoking cessation therapy and naloxone.

Page 3: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

3

In Health Systems….

• Credentialing • Document and demonstrate that the healthcare professional being evaluated has attained the credentials and qualifications to provide the scope of care expected for patient care services in a particular setting.

• Privileging• Assure stakeholders that the health care professional being considered for certain privileges has the specific competencies and experience for specific services that the organization provides and/or supports.

• http://www.pharmacycredentialing.org/Files/CCP_Special_Feature.pdf

Path Forward

• Create a dual path for the advancement of pharmacist professionally concomitantly with the advancement of opportunity for pharmacy technicians

• Expanded duties for each….as pharmacists duties change the statute and regulations back fill the tasks removed and place within the scope of the pharmacy technician

• Implement changes to definitions and application of supervision 

• Use technology to facilitate changes to pharmacist practice and abilities to supervise technician tasks

Alex J. Adams

Pre-Test Questions

True or False:1. Scope of practice is a legal construct that varies state to state.

2. The Idaho Board of Pharmacy has been authorized to create a “behind the counter” class of drugs provided certain conditions are met.

3. In Idaho, a trained and certified technician may administer any vaccine at the discretion of their supervising pharmacist.

MAY CAN

Scope of Practice

• A legal construct in which the activities that a health professional is permitted to engage in are defined by laws and regulations of the state 

• Determined by the political process

• Geographical differences; applies to all professionals in class

• Static (aside from law changes)

Clinical Ability

• The true competence and ability of the health professional

• Determined by education, training, career experience, and practice environment

• National education standards; applies to individuals

• Dynamic; advances with new education, accrued experiences, new technology, etc.

MAY CAN

The overarching goal of health professional regulation should be to harmonize clinical ability and scope of practice.

Health Professional Regulation

Page 4: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

4

Precautionary Principle

• The belief that new practices or innovations should be curtailed or disallowed until their proponents can prove that they will not cause harm.

• Fear of worst‐case scenarios• “Mother May I”

Permissionless Innovation

• The belief that experimentation with new technologies and practice models should generally be permitted by default; burden of proof on proving harm

• Allows bottom‐up solutions• Back‐end enforcement

Markers of Progressive Pharmacy PracticeAutonomous Rx Initiation

Drugs that do not require a (new) diagnosis

Drugs for conditions that are minor or self‐limiting

Drugs for conditions that have a CLIA‐waived rapid diagnostic 

test

Drugs used in an emergency situation

Collaborative Rx Initiation and/or Adaptation and/or Other Care Services

Patient‐Specific CPA (most restrictive)

Population‐Specific CPA (least restrictive)

Other Care Services

Administer vaccines

Administer other drugs

Order and interpret CLIA‐waived tests

Order and interpret non‐CLIA‐waived tests

Adapting a Rx

Extend a prescription

Make a therapeutic substitution

Change the dosage form

Change the quantity of the prescribed drug

Exercise informed intuition

• Immunizations

• Dietary fluoride supplements

• Opioid antagonists

• Epinephrine auto-injectors

• TB purified protein derivative

• Tobacco cessation medications

Idaho Autonomous Prescriptive Authority

• Drugs, drug categories or devices that are specifically authorized in rules adopted by the Board . . . limited to conditions that:• Do not require a new diagnosis; or

• Are minor and generally self-limiting; or

• Have a CLIA-waived test that is used to guide diagnosis; or

• Threaten the health and safety of the patient should the prescription not be immediately dispensed.

Idaho House Bill 191 (2017)

Technician Activities

Patient Care Activities

• Broad support for expanding the role of appropriately-trainedtechnicians

• Some pharmacists report concerns for their own liability

• Feel that as technician role expands, so should the technician’s own liability

• Pharmacists report variability in technician qualifications for expanded duties

• Critical to ensure assignment of function rests with the pharmacist

• Technicians reflect excitement about new roles and career opportunities

• Express frustration that they’ve “maxed out”

• Appreciate concept of a career ladder

Technician Advanced Roles

Page 5: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

5

Medication Dispensing Support

• Accept a verbal prescription• Clarify technical elements of 

prescription• Transfer a prescription• Search PDMP• Perform final verification of 

medications that have previously undergone DUR by a pharmacist

Technical Support for Pharmacist Clinical Services

• Administer immunizations• Administer CLIA‐waived tests• Perform basic physical 

assessment (e.g., pulse, temperature, blood pressure)

• Conduct medication reconciliation or preparatory work for MTM

Delegated Technician Authority Post-Test Questions

True or False:1. Scope of practice is a legal construct that varies state to state.

2. The Idaho Board of Pharmacy has been authorized to create a “behind the counter” class of drugs provided certain conditions are met.

3. In Idaho, a trained and certified technician may administer any vaccine at the discretion of their supervising pharmacist.

Desi Kotis, Pharm.D., FASHP

Northwestern Medicine VisionOUR VISION: 

To be a premier integrated academic health system that will serve a broad community and bring the best in medicine – including breakthrough treatments and clinical trials enhanced through our affiliation with Northwestern University Feinberg School of Medicine – to a growing number of patients close to where 

they live and work.

OUR VISION: To be a premier integrated academic health system that will serve a broad community and bring the best in medicine – including breakthrough treatments and clinical trials enhanced through our affiliation with Northwestern University Feinberg School of Medicine – to a growing number of patients close to where 

they live and work.

3

Northwestern Medicine Values

PATIENTS FIRST

Putting patients first in all we do

TEAMWORKTeam success over personal success

EXCELLENCEContinuously striving to be 

better

INTEGRITYAdhering to an uncompromising code of ethics that 

emphasizes complete honesty 

and sincerity

4

Three High Level Goals

Page 6: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

6

Advancements in Pharmacy Technician 

Pharmacy Technician

Tech‐Check‐Tech

Kit Check

Decentralized Technicians

Patient Care Advocates

Technician Manager

Pharmacy Students

Tech‐Check‐Tech

• Specialized Technician• Technician autonomy

• Expanded role

• Frees up pharmacist to focus on patient care

• Safety and Quality Assurance measures in place

RFID Technology

• Technicians have COMPLETE ownership

• System designed to accurately check trays

• Anesthesia trays 

• Emergency crash cart trays 

• Uses RFID technology to ensure accuracy of medication

About Kit Check. https://kitcheck.com/about/

Decentralized Technician

• Technician ownership of entire floor

• Faster medication delivery 

• Improved nursing and patient satisfaction

Patient Care Advocates

• Script data entry 

• Benefits investigation 

• Prior authorizations

• Financial assistance• Copay cards• Enrollment in manufacturer assistance programs• Finding funding using grants and other foundation programs

• Facilitating shipment of the drug

• Call center services• Refill management• Facilitate answering questions

Specialty Pharmacy Technicians

Promoting the Profession of Pharmacy• Co‐Funded Faculty

• Train 420 PharmD. students from eight Colleges of Pharmacy

Page 7: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

7

Pharmacy Students

• Integrated Practice Model

• Medication History and Reconciliation

• Drug information and policy

• Drug Shortages

• Flu Vaccine campaign

Practice Advancement Initiative Process

85% of hospitals have pharmacists who have 

taken a leadership role in an ASP

60% of hospitals have collaborative practice agreements with 

pharmacists and other providers

52% of pharmacy departments evaluated ways to improve the 

organization’s effectiveness as an accountable care 

organization

67% of hospitals have processes to ensure medication‐related continuity of care

68% of pharmacists in ambulatory care settings follow a standardized patient care process

http://www.ashpmedia.org/pai/docs/PAI‐Progress‐Measures.pdf

Pharmacist Lead Education• Bridge and Transition Team (BAT)

• Interdisciplinary Team

• Pharmacist role is to educate patients

Patient admitted to hospital 

flagged as BAT patient

BAT team is consulted

Prior to discharge Pharmacist leads 

medication education

Pharmacist Lead Education (cont.)

• Pharmacist centric study conducted

March 2016: BAT Team Initiated

July 2016: Cardiology Pharmacist Education 

Initiative

October 2016: Initiative Expands to General Medicine Floors

February 2017: End of Data Analysis

944 BAT patients flagged for pharmacist education

Pharmacist Lead Education (cont.)

30 Day Readmissions

30 DayReadmission Rate

Patients NOT educated by a pharmacist (n=405)

79 19.5

p = 0.017

Patients educated by a pharmacist (n=539)

74 13.7

• Pharmacist education at discharge is associated with decreased 30 day all‐cause readmission rate (19.5% v 13.7 %, p=0.017)

Emergency Department and Response 

• Pharmacist Code Response

• GEDI‐WISE Medication History• Includes Pharmacy Students

• Identifies potential medication related ED visits

• Pharmacist Driven Anticoagulation Counseling and Follow‐Up

Northwestern

Page 8: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

8

Organization Quality Metric• Antimicrobial Stewardship

Optimize Antimicrobial Therapy (TJC 6,7,8) FY16 Target Q1 Q2 Q3 Q4

FQ rate of PO utilization 52% 60% 59.1 69.9 73.2

Fluconazole rate of PO utilization 85% 87% 83.8 85.7 87.4

Reduce Incidence of c.diff (TJC 6,7,8) FY16 Target Q1 Q2 Q3 Q4

# positive HO‐C.diff tests (per month) 51 48 42 37 34

C. Diff SIR (quarterly) 1.034 0.93 0.88 0.92 0.9

HO‐C.diff rate/1000 pt days 0.70 0.66 0.58 0.5 0.47

Improve Antibiotic Education(TJC 2,5,6,7, 8) FY16 Target Q1 Q2 Q3 Q4

% appropriate CAP 87% 90% 100 96% 98%

% appropriate UTI 80% 90% 91% 94% 88%

Pharmacy Residency Program

• 10 traditional PGY1 residents 

• 4 non‐traditional PGY1 residents

• Critical Care PGY2 resident 

• 2 Hematology/Oncology PGY2 residents 

• 2 Transplant PGY2 residents 

• 1 Health‐System Administration PGY1 resident 

• 1 Infectious Diseases PGY2 resident

• 1 Emergency Medicine PGY2 resident 

• 2 Ambulatory Care PGY2 residents 

• 3 Infectious Diseases Fellows 

Part of the graduating residency and fellowship class of June 2017

The Northwestern Pharmacy Department offers a traditional PGY1 program, a non‐traditional PGY1 program, many PGY2 programs, and a fellowship in Infectious Disease. 

Residency Growth

6 6

1012

14 14 14

45

4

7

8

1513

0

5

10

15

20

25

30

35

2011‐2012 2012‐2013 2013‐2014 2014‐2015 2015‐2016 2016‐2017 2017‐2018

Residency Growth By Year

Number of PGY1s Number of PGY2s and Fellows

300%

Advancing Medical Science and Knowledge

Note:  Presentations includes presentations, posters, workshops, case studies, and panel discussions. 

28 47 53 56 75 86 86 82 852321 24 29

3550 60

40 48

2733 31

4646

49 5060

69

0

50

100

150

200

250

2008 2009 2010 2011 2012 2013 2014 2015 2016

PHARMACY:    Publication, Presentation and Research Activity

Presentation Publication Research Studies

300%

Advancing Medical Science and KnowledgeRecent Publications

Miglis, C., Rhodes, N., Avedissian, S., Zembower, T., Postelnick, M., Wunderink, R., . . . Scheetz, M. A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and Underutilization. Infection Control & Hospital Epidemiology, 2017, 38(7), 860‐862. 

Miglis C, Rhodes NJ, Kuti JL, Nicolau DP, Van Wart SA, Scheetz MH. Defining the impact of severity of illness on time above the MIC threshold for cefepime in gram‐negative bacteremia: a 'goldilocks' window. Int J Antimicrob Agents. 2017 Jun 28. pii: S0924‐8579(17)30237‐6. doi: 10.1016/j.ijantimicag.2017.04.023.  [Epub ahead of print] PubMed PMID: 28668683.

Gilbert EM, Zembower TR, Rhodes NJ, Qi C, Reiner S, Malczynski M, Scheetz MH. Factors contributing to vancomycin‐resistant Enterococcus spp. Horizontal transmission events: exploration of the role of antibacterial consumption. Diagn Microbiol Infect Dis. 2017 Jun 2. pii: S0732‐8893(17)30174‐8.  doi: 10.1016/j.diagmicrobio.2017.05.014.  [Epub ahead of print] PubMed PMID: 28669681.

Rhodes NJ, Grove ME, Kiel PJ, O'Donnell JN, Whited LK, Rose DT, Jones DR, Scheetz MH. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose‐dependent susceptibility and contemporary dosing regimens. Int J Antimicrob Agents. 2017 Jun 28. pii: S0924‐8579(17)30200‐5. doi: 10.1016/j.ijantimicag.2017.04.008. [Epub ahead of print] PubMed PMID: 28668694.

Rhodes, N., Gilbert, E., Skoglund, E., Esterly, J., Postelnick, M., McLaughlin, M. Prediction of inventory sustainability during a drug shortage. American Journal of Health‐System Pharmacy Jul 2016, 73 (14) 1094‐1098; DOI: 10.2146/ajhp150532 

Watson WA, Rhodes NJ, Echenique IA, Angarone MP, Scheetz MH. Resolution of acyclovir‐associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature. J Clin Pharm Ther. 2017 Jun;42(3):350‐355. doi: 10.1111/jcpt.12520. Epub 2017 Mar 29. PubMed PMID: 28370067; PubMed Central PMCID: PMC5404941

Scheetz MH, Crew PE, Miglis C, et al. Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework. Antimicrobial Agents and Chemotherapy. 2016;60(6):3265‐3269. doi:10.1128/AAC.00572‐16.

Maas MB, Francis BA, Sangha RS, Lizza BD, Liotta E, M, Naidech A, M, Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment. Cerebrovasc Dis 2017;43:110‐116

Rhodes NJ, Wagner JL, Gilbert EM, Crew PE, Davis SL, Scheetz MH. Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption  Metrics. Infect Control Hosp Epidemiol. 2016 Aug;37(8):971‐3. doi: 10.1017/ice.2016.109. Epub 2016 May 13. PubMed PMID: 27174570.

Lizza BD, Rhodes NJ, Esterly JS, Scheetz MH, Impact of body mass index on clinical outcomes in patients with gram‐negative bacteria bloodstream infections, Journal of Infection and Chemotherapy, Volume 22, Issue 10, 2016, Pages 671‐676, ISSN 1341‐321X,

E. M. Liotta, B. D. Lizza, A. L. Romanova et al., “23.4% Saline decreases brain tissue volume in severe hepatic encephalopathy as assessed by a quantitative CT marker,” Critical Care Medicine, vol. 44, no. 1, pp. 171–179, 2016

Ellinger LK. Research study design. In: Gabay M, ed. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett Learning; 2016:125‐137.

Phatak A, Prusi R, Ward B, Hansen LO, Williams MV, Vetter E, Chapman N, Postelnick M, Pharmacist Impact on Transitional Care. J. Hosp. Med2016;1;39‐44. doi:10.1002/jhm.2493

Prothrombin Complex Concentrate Reduces Intraoperative Blood Product Utilization in Heart Transplantation, Enter, D. Marsh, M, Melody, N et al. The Journal of Heart and Lung Transplantation , 2017, Volume 35 , Issue 4 , S293

Chapter 7: Research Study Design, Lara Ellinger

Changing Health OutcomesAmbulatory Care

Patients First

• Integrated specialty medication management (Available 24/7)

• Navigation of patients through the complex process

• Smooth transitions in care (Medication to bedside prior to discharge)

Safety Always

• Work alongside care team to ensure safe medication use

• Side effects are minimized and managed appropriately

• Patients receive education and follow up monitoring

Financial Stewardship

• Generate financial resources (profit margin)

• Optimize care and outcomes

• Strategic positioning for ACO model

Exceptional Patient Experience

Page 9: 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and qualifications to provide the scope of care expected for patient care services in

9/1/2017

9

Ambulatory Care Patients Achieve Desired Outcomes

September 2015 through August 2016

• 396 total patients received therapy management at NM• 261 completed therapy 

• HCV RNA undetectable lab results

• 96% ‐ Cure rate for patients who receive therapy management

• 11 patients have shown HCV RNA detectable lab results at the end of therapy

• Complex transplant or co‐infected patients

• 124 remaining are completing therapy• Projecting undetectable HCV RNA according to most recent lab test

Hepatitis C Clinical Outcomes

50

Questions?


Recommended